John W. Burch

Inhibition of platelet prostaglandin synthetase by oral aspirin.

John W. Burch, N Stanford, Philip W. Majerus · Journal of Clinical Investigation · 1978 · 555 citations · Full text

Thrombosis, Blood Platelet, Medicine +10

Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose Aspirin

Herschel R. Harter, John W. Burch, Philip W. Majerus et al. · New England Journal of Medicine · 1979 · 250 citations

Platelet Cyclo-oxygenase, Dialysis Therapy, Pharmacotherapy +21

Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin.

John W. Burch, Nancy Lewis Baenziger, N Stanford et al. · Proceedings of the National Academy of Sciences · 1978 · 149 citations · Full text

Vascular Disease, Human Aorta, Fatty Acid Cyclooxygenase +20

Direct interaction of mepacrine with erythrocyte and platelet membrane phospholipid.

Craig A. Dise, John W. Burch, David B. P. Goodman · Journal of Biological Chemistry · 1982 · 122 citations · Full text

Proteinlipid Interaction, Lipid Environment, Molecular Physiology +14

A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.

Joel Bennett, Gaston Vilaire, John W. Burch · Journal of Clinical Investigation · 1981 · 79 citations · Full text

Immunology, Pharmacotherapy, Platelet Aggregation +19